TGFB1 and mature T-cell and NK-cell non-Hodgkin lymphoma: Based on the fact that TCLlnc1 promoted both tumor growth and the migration of PTCL via TGF-β signaling activation, therapeutic targeting of TGF-β may counteract tumor progression in PTCL with TCLlnc1 overexpression.